Electrocardiograph

With globally recognized Glasgow 12-lead analysis and easy-to-use technology, Mindray’s BeneHeart R3/R12 electrocardiographs are able to meet a range of different clinical demands.

\r\n"}}" id="text-789173e52e" class="8f00b2 cmp-text">

With globally recognized Glasgow 12-lead analysis and easy-to-use technology, Mindray’s BeneHeart R3/R12 electrocardiographs are able to meet a range of different clinical demands.

Insights

The 2009 AHA/ACCF/HRS recommendations have new ST elevation myocardial infarction (STEMI) criteria that now depend on both age and gender. In addition, the patient’s race, medication history, etc. will also affect the results of an ECG interpretation. The physiological structure of newborns and infants is slightly different from that of adults - the right ventricle is larger and thicker than the left ventricle. Therefore, a special algorithm for pediatric use is required to provide more reliable and accurate diagnoses.

Glasgow 12-lead analysis

The industry-recognized Glasgow 12-lead analysis supports diagnostic confidence around the world. Accurate diagnosis in adults and children from birth upwards. Continuous development of the Glasgow algorithm for over 40 years delivers one of the world's best methods of ECG analysis.

Digital pacemaker detection

Digital pacemaker detection provides reliable report of atrial, ventricular and A-V sequential pacing mode without selecting pacemaker detection sensitivity.

BeneHeart R12

The BeneHeart R12 is a twelve-channel ECG device with user-friendly design which features a reliable internal analysis algorithm, the Glasgow algorithm. There are many functions such as report preview and touch screen which help to streamline the workflow.

Learn more >

Electrocardiograph Products

BeneHeart Series